Dissociative steroid
Vamorolone
Brand names: Agamree
Adult dose
Dose: 6 mg/kg PO OD with food (max 300mg/day)
Route: PO
Frequency: OD
Clinical pearls
- Duchenne muscular dystrophy (≥4 years) — alternative to prednisolone
- Per NICE TA1029
Contraindications
- Untreated systemic infection
- Live vaccines
- Hypersensitivity
Side effects
- Cushingoid features (less than prednisolone)
- HPA suppression
- Behavioural changes
- Vitamin D deficiency
- Hyperglycaemia
Interactions
- CYP3A4 modulators
- Live vaccines
Monitoring
- BMD
- Growth
- Adrenal function
Reference: BNF; NICE TA1029; SmPC; https://bnf.nice.org.uk/drugs/vamorolone/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Pathways
- Acute Stroke / TIA Assessment · NICE NG128; RCP Stroke Guidelines 2023
- Status Epilepticus (Adults) · NICE CG137; ESEM guidelines; RCP Neurology Guidelines
- Suspected Subarachnoid Haemorrhage · NICE NG228; RCEM 2023; AHA/ASA 2023
- Adult Head Injury · NICE NG232 (2023)
- Bell's Palsy / Facial Nerve Palsy · ENT UK 2017; AAN
- Vertigo Workup · ENT UK; NICE CKS